Polymyalgia rheumatica (PMR) is characterized by myalgia and severe stiffness with decreased range of motion in the shoulder and pelvic girdles. The efficacy of the BNT 162b2 Pfizer vaccine has been proven and has been well-tolerated by patients; however, some instances of PMR have been reported after the COVID-19 vaccine. We are writing a case of a new-onset PMR in a 72-year-old woman with typical findings after receiving a booster dose of the BNT 162b2 Pfizer vaccine. This case report highlights that PMR should be in the differential diagnosis of myalgias caused by the vaccine.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356652 | PMC |
| http://dx.doi.org/10.7759/cureus.26617 | DOI Listing |
Publication Analysis
Top Keywords
covid-19 vaccine
8
polymyalgia rheumatica
8
bnt 162b2
8
162b2 pfizer
8
pfizer vaccine
8
vaccine
5
unusual side
4
side covid-19
4
vaccine trigger
4
trigger polymyalgia
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!